Herdon HJ - Search Results

1

Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands.

Herdon HJ, Roberts JC, Coulton S, Porter RA. Herdon HJ, et al. Neuropharmacology. 2010 Nov;59(6):558-65. doi: 10.1016/j.neuropharm.2010.07.023. Epub 2010 Aug 5. Neuropharmacology. 2010. PMID: 20691713

2

Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.

Kalinichev M, Starr KR, Teague S, Bradford AM, Porter RA, Herdon HJ. Kalinichev M, et al. Among authors: herdon hj. Brain Res. 2010 May 17;1331:105-13. doi: 10.1016/j.brainres.2010.03.032. Epub 2010 Mar 18. Brain Res. 2010. PMID: 20303337

3

Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes.

Herdon HJ, Godfrey FM, Brown AM, Coulton S, Evans JR, Cairns WJ. Herdon HJ, et al. Neuropharmacology. 2001 Jul;41(1):88-96. doi: 10.1016/s0028-3908(01)00043-0. Neuropharmacology. 2001. PMID: 11445189

4

Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.

Langmead CJ, Jerman JC, Brough SJ, Scott C, Porter RA, Herdon HJ. Langmead CJ, et al. Among authors: herdon hj. Br J Pharmacol. 2004 Jan;141(2):340-6. doi: 10.1038/sj.bjp.0705610. Epub 2003 Dec 22. Br J Pharmacol. 2004. PMID: 14691055 Free PMC article.

5

SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia.

Benham CD, Brown TH, Cooper DG, Evans ML, Harries MH, Herdon HJ, Meakin JE, Murkitt KL, Patel SR, Roberts JC, et al. Benham CD, et al. Among authors: herdon hj. Neuropharmacology. 1993 Nov;32(11):1249-57. doi: 10.1016/0028-3908(93)90019-y. Neuropharmacology. 1993. PMID: 8107976

6

Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography.

Passchier J, Gentile G, Porter R, Herdon H, Salinas C, Jakobsen S, Audrain H, Laruelle M, Gunn RN. Passchier J, et al. Synapse. 2010 Jul;64(7):542-9. doi: 10.1002/syn.20760. Synapse. 2010. PMID: 20196141

7

Use of the radioligand [(125)I]-SB-217644 in the characterisation and solubilisation of the novel binding site for the anticonvulsant SB-204269 in rat brain membranes and cell lines.

Herdon HJ, Godfrey FM, Chan WN. Herdon HJ, et al. Neuropharmacology. 2000 Sep;39(12):2457-63. doi: 10.1016/s0028-3908(00)00071-x. Neuropharmacology. 2000. PMID: 10974330

8

Acylglycinamides as inhibitors of glycine transporter type 1.

Blunt R, Porter R, Johns A, Nash D, Puckey G, Wyman P, Herdon H, Teague S, Hadden V, Fontana S, Gordon L. Blunt R, et al. Bioorg Med Chem Lett. 2011 Oct 15;21(20):6176-9. doi: 10.1016/j.bmcl.2011.07.096. Epub 2011 Aug 6. Bioorg Med Chem Lett. 2011. PMID: 21889344

9

1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1.

Rahman SS, Coulton S, Herdon HJ, Joiner GF, Jin J, Porter RA. Rahman SS, et al. Among authors: herdon hj. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1741-5. doi: 10.1016/j.bmcl.2006.12.063. Epub 2006 Dec 22. Bioorg Med Chem Lett. 2007. PMID: 17234406

10

Cloning, functional characterisation and population analysis of a variant form of the human glycine type 2 transporter.

Evans J, Herdon H, Cairns W, O'Brien E, Chapman C, Terrett J, Gloger I. Evans J, et al. FEBS Lett. 1999 Dec 17;463(3):301-6. doi: 10.1016/s0014-5793(99)01636-1. FEBS Lett. 1999. PMID: 10606742 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters